AMRZ:SIXAmrize Ltd Analysis

Amrize Ltd (AMRZ) trades at $59.77, comfortably above its DCF fair value of $30.90, suggesting the market is pricing in strong growth expectations. The stock sits above its 50‑day ($57.77) and 200‑day ($52.78) simple moving averages, confirming a bullish longer‑term trend, yet it remains below the 20‑day SMA ($61.75) and the MACD histogram is negative, indicating short‑term bearish pressure. Technical momentum is neutral with an RSI of 48.8 and a decreasing volume trend, while a beta of 1.26 and 30‑day volatility of 48.6% point to heightened price swings. Recent earnings showed a modest revenue increase to $11.8 bn and an adjusted EBITDA of $3 bn, with forward EPS projected at $3.18, supporting a forward PE of 18.8 versus a trailing PE of 27.9. Management’s 2026 guidance targets 4‑6% revenue growth and $900 m capex, underscoring confidence in demand recovery. The company’s balance sheet shows a high debt‑to‑equity ratio of 47.9, but it generates strong operating cash flow ($2.21 bn) and free cash flow ($1.58 bn). The market sentiment is at an Extreme Greed level (81.5 on the Fear‑Greed Index), and analysts collectively rate the stock as a “Buy” with a median target of $69, implying ~15% upside from current levels.
Given the blend of solid fundamentals, positive guidance, and a fair to slightly overvalued market price, the stock presents a balanced risk‑reward profile. The high volatility and beta suggest caution for short‑term traders, but the bullish long‑term trend and sector demand for building materials support a buy stance over medium to long horizons. Liquidity remains adequate despite a recent dip in volume, and the absence of a dividend eliminates yield concerns. Overall, AMRZ appears positioned for incremental upside if the growth outlook materializes, while technical headwinds warrant a measured approach.